y 26611 has been researched along with 8-fluorociprofloxacin in 1 studies
| Studies (y 26611) | Trials (y 26611) | Recent Studies (post-2010) (y 26611) | Studies (8-fluorociprofloxacin) | Trials (8-fluorociprofloxacin) | Recent Studies (post-2010) (8-fluorociprofloxacin) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 13 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, K; Hirayama, F; Ikeda, Y; Iwao, E; Kuroda, T; Moriguchi, A; Uemori, S; Yakushiji, T; Yokoyama, Y | 1 |
1 other study(ies) available for y 26611 and 8-fluorociprofloxacin
| Article | Year |
|---|---|
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Escherichia coli; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Morpholines; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 1993 |